Azelastin Fluticason Sandoz Nasenspray
Azelastin Fluticason Sandoz Nasenspray is a medicine authorised by Swissmedic under authorisation number 69878. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 20 November 2025 and the authorisation is limited until 19 November 2030. ATC code R01AD58 places the medicine in the group Nasal preparations.
| Authorisation number | 69878 |
|---|---|
| Name | Azelastin Fluticason Sandoz Nasenspray |
| Full name | Azelastin Fluticason Sandoz Nasenspray, Suspension |
| Authorisation holder | Sandoz Pharmaceuticals AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R01AD58 |
| First authorisation | 20 November 2025 |
| Authorisation validity | 19 November 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Azelastin Fluticason Sandoz Nasenspray, Suspension | B | 20 November 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 120 | Einzeldose(n) | R01AD58 | 12.02.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Azelastin Fluticason Sandoz Nasenspray authorised in Switzerland?
Yes. Azelastin Fluticason Sandoz Nasenspray is authorised by Swissmedic under authorisation number 69878, data as of 01 September 2026. The authorisation is limited until 19 November 2030.
Which dispensing category does Azelastin Fluticason Sandoz Nasenspray have?
Azelastin Fluticason Sandoz Nasenspray is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Azelastin Fluticason Sandoz Nasenspray?
The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.